Novel motif:153: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif153_ACTYNYYATYG
|novel_motifs_human_sample_pval=11376-118A8_11051;0.15747,11327-117E4_11969;0.640081,11473-119C6_11054;0.126556,11474-119C7_12067;0....") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:22, 9 September 2013
name: | motif153_ACTYNYYATYG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.305673e-11 |
GO:0040040 | thermosensory behavior | 1.609082e-10 |
GO:0071460 | cellular response to cell-matrix adhesion | 4.110834e-10 |
GO:0050999 | regulation of nitric-oxide synthase activity | 5.433941e-10 |
GO:0030574 | collagen catabolic process | 6.698434e-10 |
GO:0009072 | aromatic amino acid family metabolic process | 2.056962e-9 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 2.634688e-9 |
GO:0045209 | MAPK phosphatase export from nucleus, leptomycin B sensitive | 3.978681e-9 |
GO:0045204 | MAPK export from nucleus | 3.978681e-9 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 5.756454e-9 |
GO:0006663 | platelet activating factor biosynthetic process | 7.424557e-9 |
GO:0051649 | establishment of localization in cell | 8.456033e-9 |
GO:0090130 | tissue migration | 1.649475e-8 |
GO:0000414 | regulation of histone H3-K36 methylation | 2.944354e-8 |
GO:0010631 | epithelial cell migration | 3.390282e-8 |
GO:0030168 | platelet activation | 4.311490e-8 |
GO:0051641 | cellular localization | 9.461201e-8 |
GO:0051902 | negative regulation of mitochondrial depolarization | 1.071276e-7 |
GO:0046469 | platelet activating factor metabolic process | 1.251453e-7 |
GO:0046486 | glycerolipid metabolic process | 1.566699e-7 |
GO:0000278 | mitotic cell cycle | 2.429381e-7 |
GO:0051569 | regulation of histone H3-K4 methylation | 2.641638e-7 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 3.101245e-7 |
GO:0070189 | kynurenine metabolic process | 3.850242e-7 |
GO:0048294 | negative regulation of isotype switching to IgE isotypes | 4.095433e-7 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 6.281752e-7 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.360194e-7 |
GO:0051341 | regulation of oxidoreductase activity | 6.450695e-7 |
GO:0070625 | zymogen granule exocytosis | 6.594519e-7 |
GO:0006650 | glycerophospholipid metabolic process | 6.624029e-7 |
GO:2000685 | positive regulation of cellular response to X-ray | 8.224973e-7 |
GO:2001038 | regulation of cellular response to drug | 8.224973e-7 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 8.224973e-7 |
GO:0035978 | histone H2A-S139 phosphorylation | 8.224973e-7 |
GO:0031052 | chromosome breakage | 8.224973e-7 |
GO:0003131 | mesodermal-endodermal cell signaling | 8.224973e-7 |
GO:0051900 | regulation of mitochondrial depolarization | 8.490478e-7 |
GO:0042158 | lipoprotein biosynthetic process | 1.057749e-6 |
GO:0019748 | secondary metabolic process | 1.135987e-6 |
GO:0042157 | lipoprotein metabolic process | 1.223934e-6 |
GO:0007093 | mitotic cell cycle checkpoint | 1.274008e-6 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.381326e-6 |
GO:0015696 | ammonium transport | 1.381326e-6 |
GO:0019441 | tryptophan catabolic process to kynurenine | 1.484479e-6 |
GO:0006582 | melanin metabolic process | 1.628151e-6 |
GO:0006497 | protein lipidation | 1.741250e-6 |
GO:0009607 | response to biotic stimulus | 1.747554e-6 |
GO:0045738 | negative regulation of DNA repair | 1.886507e-6 |
GO:0032768 | regulation of monooxygenase activity | 2.031222e-6 |
GO:0019087 | transformation of host cell by virus | 2.059083e-6 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 2.424220e-6 |
GO:0007052 | mitotic spindle organization | 2.550942e-6 |
GO:0006886 | intracellular protein transport | 2.920307e-6 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 2.977020e-6 |
GO:0001775 | cell activation | 3.020321e-6 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 3.180265e-6 |
GO:0045910 | negative regulation of DNA recombination | 3.454551e-6 |
GO:0009617 | response to bacterium | 3.596738e-6 |
GO:0019439 | aromatic compound catabolic process | 4.038723e-6 |
GO:0046007 | negative regulation of activated T cell proliferation | 4.087014e-6 |
GO:0030573 | bile acid catabolic process | 4.633789e-6 |
GO:0014739 | positive regulation of muscle hyperplasia | 4.662779e-6 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 4.715341e-6 |
GO:0001836 | release of cytochrome c from mitochondria | 4.797510e-6 |
GO:0006657 | CDP-choline pathway | 4.915124e-6 |
GO:0007265 | Ras protein signal transduction | 4.974521e-6 |
GO:0015808 | L-alanine transport | 4.989373e-6 |
GO:0016486 | peptide hormone processing | 5.166532e-6 |
GO:0043922 | negative regulation by host of viral transcription | 5.345491e-6 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 5.843817e-6 |
GO:0034374 | low-density lipoprotein particle remodeling | 5.910470e-6 |
GO:0071780 | mitotic cell cycle G2/M transition checkpoint | 6.276334e-6 |
GO:0009074 | aromatic amino acid family catabolic process | 6.340872e-6 |
GO:0008090 | retrograde axon cargo transport | 6.983509e-6 |
GO:0045851 | pH reduction | 7.296870e-6 |
GO:0044243 | multicellular organismal catabolic process | 7.390649e-6 |
GO:0072091 | regulation of stem cell proliferation | 7.492706e-6 |
GO:0051452 | intracellular pH reduction | 7.497946e-6 |
GO:0045759 | negative regulation of action potential | 7.747428e-6 |
GO:0007018 | microtubule-based movement | 7.876697e-6 |
GO:0045191 | regulation of isotype switching | 8.104163e-6 |
GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 8.302578e-6 |
GO:0032328 | alanine transport | 9.288083e-6 |
GO:0090398 | cellular senescence | 9.543251e-6 |
GO:0051298 | centrosome duplication | 9.758053e-6 |
GO:0060236 | regulation of mitotic spindle organization | 9.881096e-6 |
GO:0014074 | response to purine-containing compound | 1.000999e-5 |
GO:0010469 | regulation of receptor activity | 1.010953e-5 |
GO:0032409 | regulation of transporter activity | 1.033664e-5 |
GO:0071827 | plasma lipoprotein particle organization | 1.042263e-5 |
GO:0051707 | response to other organism | 1.050046e-5 |
GO:0048251 | elastic fiber assembly | 1.170447e-5 |
GO:0022402 | cell cycle process | 1.191451e-5 |
GO:0051329 | interphase of mitotic cell cycle | 1.204634e-5 |
GO:0090402 | oncogene-induced senescence | 1.205613e-5 |
GO:0045091 | regulation of retroviral genome replication | 1.387590e-5 |
GO:2000779 | regulation of double-strand break repair | 1.387590e-5 |
GO:0035988 | chondrocyte proliferation | 1.396340e-5 |
GO:0051702 | interaction with symbiont | 1.433590e-5 |
GO:0045869 | negative regulation of retroviral genome replication | 1.584738e-5 |
GO:0051255 | spindle midzone assembly | 1.618423e-5 |
GO:0015827 | tryptophan transport | 1.618423e-5 |
GO:0006569 | tryptophan catabolic process | 1.627547e-5 |
GO:0090307 | spindle assembly involved in mitosis | 1.714744e-5 |
GO:0051592 | response to calcium ion | 1.759315e-5 |
GO:0006568 | tryptophan metabolic process | 1.858097e-5 |
GO:0071615 | oxidative deethylation | 1.964077e-5 |
GO:0009403 | toxin biosynthetic process | 1.964077e-5 |
GO:0032958 | inositol phosphate biosynthetic process | 2.018096e-5 |
GO:0051482 | elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger | 2.019469e-5 |
GO:2000648 | positive regulation of stem cell proliferation | 2.029860e-5 |
GO:0006605 | protein targeting | 2.030685e-5 |
GO:0008088 | axon cargo transport | 2.052769e-5 |
GO:0051549 | positive regulation of keratinocyte migration | 2.111144e-5 |
GO:0022898 | regulation of transmembrane transporter activity | 2.160042e-5 |
GO:0034369 | plasma lipoprotein particle remodeling | 2.197127e-5 |
GO:0032412 | regulation of ion transmembrane transporter activity | 2.210374e-5 |
GO:0070997 | neuron death | 2.359666e-5 |
GO:0006586 | indolalkylamine metabolic process | 2.394551e-5 |
GO:0007067 | mitosis | 2.401078e-5 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 2.408296e-5 |
GO:0085029 | extracellular matrix assembly | 2.412599e-5 |
GO:0032897 | negative regulation of viral transcription | 2.437157e-5 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 2.540406e-5 |
GO:0032514 | positive regulation of protein phosphatase type 2B activity | 2.967030e-5 |
GO:0051402 | neuron apoptosis | 2.980874e-5 |
GO:0048599 | oocyte development | 3.000895e-5 |
GO:0002456 | T cell mediated immunity | 3.072904e-5 |
GO:0032075 | positive regulation of nuclease activity | 3.083739e-5 |
GO:0051325 | interphase | 3.159035e-5 |
GO:0035094 | response to nicotine | 3.215265e-5 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 3.269466e-5 |
GO:0060623 | regulation of chromosome condensation | 3.307377e-5 |
GO:0071283 | cellular response to iron(III) ion | 3.307377e-5 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 3.307377e-5 |
GO:0046680 | response to DDT | 3.307377e-5 |
GO:0046148 | pigment biosynthetic process | 3.353483e-5 |
GO:0042771 | DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | 3.611585e-5 |
GO:0016572 | histone phosphorylation | 3.809358e-5 |
GO:0051497 | negative regulation of stress fiber assembly | 3.853267e-5 |
GO:0000087 | M phase of mitotic cell cycle | 4.058127e-5 |
GO:0031000 | response to caffeine | 4.119339e-5 |
GO:0046907 | intracellular transport | 4.412298e-5 |
GO:0022403 | cell cycle phase | 4.569468e-5 |
GO:0035966 | response to topologically incorrect protein | 4.606524e-5 |
GO:0009994 | oocyte differentiation | 4.958520e-5 |
GO:0042438 | melanin biosynthetic process | 5.066876e-5 |
GO:0007154 | cell communication | 5.178836e-5 |
GO:0050690 | regulation of defense response to virus by virus | 5.205486e-5 |
GO:0043921 | modulation by host of viral transcription | 5.297525e-5 |
GO:0031396 | regulation of protein ubiquitination | 5.514319e-5 |
GO:0051188 | cofactor biosynthetic process | 5.606687e-5 |
GO:0051453 | regulation of intracellular pH | 5.783380e-5 |
GO:0006282 | regulation of DNA repair | 5.978158e-5 |
GO:0010189 | vitamin E biosynthetic process | 6.279221e-5 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 6.364761e-5 |
GO:0042473 | outer ear morphogenesis | 6.376941e-5 |
GO:0002316 | follicular B cell differentiation | 6.511037e-5 |
GO:0042440 | pigment metabolic process | 6.804619e-5 |
GO:0045471 | response to ethanol | 7.140032e-5 |
GO:0051234 | establishment of localization | 7.194581e-5 |
GO:0034622 | cellular macromolecular complex assembly | 7.556503e-5 |
GO:0006878 | cellular copper ion homeostasis | 7.776152e-5 |
GO:0006508 | proteolysis | 7.784452e-5 |
GO:0032512 | regulation of protein phosphatase type 2B activity | 7.844737e-5 |
GO:0030277 | maintenance of gastrointestinal epithelium | 7.860690e-5 |
GO:0002576 | platelet degranulation | 7.923418e-5 |
GO:0048753 | pigment granule organization | 7.986544e-5 |
GO:0043623 | cellular protein complex assembly | 8.008423e-5 |
GO:0035986 | senescence-associated heterochromatin focus formation | 8.240176e-5 |
GO:2000774 | positive regulation of cellular senescence | 8.240176e-5 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 8.305004e-5 |
GO:0060282 | positive regulation of oocyte development | 8.330057e-5 |
GO:0046716 | muscle cell homeostasis | 8.332839e-5 |
GO:0051052 | regulation of DNA metabolic process | 8.522136e-5 |
GO:0010038 | response to metal ion | 8.531449e-5 |
GO:0032465 | regulation of cytokinesis | 9.033024e-5 |
GO:0003254 | regulation of membrane depolarization | 9.044238e-5 |
GO:0006950 | response to stress | 9.296232e-5 |
GO:0051256 | spindle midzone assembly involved in mitosis | 9.387098e-5 |
GO:0006868 | glutamine transport | 9.621848e-5 |
GO:0070482 | response to oxygen levels | 9.994021e-5 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 1.046978e-4 |
GO:0002637 | regulation of immunoglobulin production | 1.057369e-4 |
GO:0048285 | organelle fission | 1.061821e-4 |
GO:0031576 | G2/M transition checkpoint | 1.066920e-4 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 1.079044e-4 |
GO:0006338 | chromatin remodeling | 1.105716e-4 |
GO:0000077 | DNA damage checkpoint | 1.149381e-4 |
GO:0043691 | reverse cholesterol transport | 1.168701e-4 |
GO:0045110 | intermediate filament bundle assembly | 1.187180e-4 |
GO:0021680 | cerebellar Purkinje cell layer development | 1.193105e-4 |
GO:0030091 | protein repair | 1.218485e-4 |
GO:0031639 | plasminogen activation | 1.256977e-4 |
GO:0030003 | cellular cation homeostasis | 1.279337e-4 |
GO:0007098 | centrosome cycle | 1.321361e-4 |
GO:0032963 | collagen metabolic process | 1.408535e-4 |
GO:0050973 | detection of mechanical stimulus involved in equilibrioception | 1.448618e-4 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.448618e-4 |
GO:0051272 | positive regulation of cellular component movement | 1.465966e-4 |
GO:0032411 | positive regulation of transporter activity | 1.532934e-4 |
GO:0051788 | response to misfolded protein | 1.569061e-4 |
GO:0043420 | anthranilate metabolic process | 1.594914e-4 |
GO:0034516 | response to vitamin B6 | 1.594914e-4 |
GO:0048747 | muscle fiber development | 1.615684e-4 |
GO:0006434 | seryl-tRNA aminoacylation | 1.663267e-4 |
GO:0031507 | heterochromatin formation | 1.694734e-4 |
GO:0050871 | positive regulation of B cell activation | 1.699752e-4 |
GO:0060249 | anatomical structure homeostasis | 1.706003e-4 |
GO:0072331 | signal transduction by p53 class mediator | 1.706751e-4 |
GO:0046885 | regulation of hormone biosynthetic process | 1.724694e-4 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 1.739885e-4 |
GO:0048660 | regulation of smooth muscle cell proliferation | 1.781128e-4 |
GO:0010669 | epithelial structure maintenance | 1.799553e-4 |
GO:0009628 | response to abiotic stimulus | 1.815749e-4 |
GO:0055070 | copper ion homeostasis | 1.817620e-4 |
GO:0043279 | response to alkaloid | 1.847181e-4 |
GO:0032496 | response to lipopolysaccharide | 1.912691e-4 |
GO:0035967 | cellular response to topologically incorrect protein | 1.941147e-4 |
GO:0043148 | mitotic spindle stabilization | 1.985272e-4 |
GO:0035026 | leading edge cell differentiation | 1.996458e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.038385e-4 |
GO:0042360 | vitamin E metabolic process | 2.041321e-4 |
GO:0009108 | coenzyme biosynthetic process | 2.056776e-4 |
GO:0006979 | response to oxidative stress | 2.068274e-4 |
GO:0043968 | histone H2A acetylation | 2.086009e-4 |
GO:0010863 | positive regulation of phospholipase C activity | 2.097131e-4 |
GO:0006644 | phospholipid metabolic process | 2.217767e-4 |
GO:0051303 | establishment of chromosome localization | 2.250086e-4 |
GO:0001816 | cytokine production | 2.275621e-4 |
GO:0009312 | oligosaccharide biosynthetic process | 2.297469e-4 |
GO:0031959 | mineralocorticoid receptor signaling pathway | 2.317581e-4 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 2.369870e-4 |
GO:0051704 | multi-organism process | 2.403172e-4 |
GO:0032769 | negative regulation of monooxygenase activity | 2.415299e-4 |
GO:0045793 | positive regulation of cell size | 2.417723e-4 |
GO:0009395 | phospholipid catabolic process | 2.450345e-4 |
GO:0007346 | regulation of mitotic cell cycle | 2.496738e-4 |
GO:0051179 | localization | 2.526314e-4 |
GO:0060281 | regulation of oocyte development | 2.544452e-4 |
GO:0019442 | tryptophan catabolic process to acetyl-CoA | 2.550265e-4 |
GO:0008203 | cholesterol metabolic process | 2.565861e-4 |
GO:0046689 | response to mercury ion | 2.580620e-4 |
GO:0035025 | positive regulation of Rho protein signal transduction | 2.590775e-4 |
GO:0019218 | regulation of steroid metabolic process | 2.607881e-4 |
GO:0006883 | cellular sodium ion homeostasis | 2.656016e-4 |
GO:0008637 | apoptotic mitochondrial changes | 2.689077e-4 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 2.690472e-4 |
GO:0000296 | spermine transport | 2.760624e-4 |
GO:0031570 | DNA integrity checkpoint | 2.794898e-4 |
GO:0023052 | signaling | 2.828451e-4 |
GO:0034063 | stress granule assembly | 2.841469e-4 |
GO:0030641 | regulation of cellular pH | 2.931252e-4 |
GO:0009611 | response to wounding | 2.941053e-4 |
GO:0006810 | transport | 3.016081e-4 |
GO:0018874 | benzoate metabolic process | 3.185511e-4 |
GO:0009311 | oligosaccharide metabolic process | 3.198551e-4 |
GO:0033124 | regulation of GTP catabolic process | 3.355176e-4 |
GO:0043438 | acetoacetic acid metabolic process | 3.454873e-4 |
GO:0002829 | negative regulation of type 2 immune response | 3.515389e-4 |
GO:0045143 | homologous chromosome segregation | 3.791555e-4 |
GO:0060033 | anatomical structure regression | 3.871583e-4 |
GO:0006629 | lipid metabolic process | 3.916247e-4 |
GO:0009408 | response to heat | 3.920391e-4 |
GO:0006458 | 'de novo' protein folding | 3.923617e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 3.926692e-4 |
GO:0022037 | metencephalon development | 4.015205e-4 |
GO:0007596 | blood coagulation | 4.036144e-4 |
GO:0055001 | muscle cell development | 4.076160e-4 |
GO:0010212 | response to ionizing radiation | 4.095156e-4 |
GO:0006706 | steroid catabolic process | 4.148939e-4 |
GO:0035404 | histone-serine phosphorylation | 4.169365e-4 |
GO:0016139 | glycoside catabolic process | 4.384595e-4 |
GO:0009314 | response to radiation | 4.391677e-4 |
GO:0034621 | cellular macromolecular complex subunit organization | 4.417900e-4 |
GO:0002237 | response to molecule of bacterial origin | 4.495058e-4 |
GO:0030335 | positive regulation of cell migration | 4.542967e-4 |
GO:0019538 | protein metabolic process | 4.591353e-4 |
GO:0040001 | establishment of mitotic spindle localization | 4.609003e-4 |
GO:0010810 | regulation of cell-substrate adhesion | 4.635745e-4 |
GO:0006612 | protein targeting to membrane | 4.732322e-4 |
GO:0051053 | negative regulation of DNA metabolic process | 4.838149e-4 |
GO:0006814 | sodium ion transport | 4.861159e-4 |
GO:0007599 | hemostasis | 4.905959e-4 |
GO:0031958 | corticosteroid receptor signaling pathway | 4.992676e-4 |
GO:0001953 | negative regulation of cell-matrix adhesion | 5.013425e-4 |
GO:0044255 | cellular lipid metabolic process | 5.042094e-4 |
GO:0030719 | P granule organization | 5.133649e-4 |
GO:0034103 | regulation of tissue remodeling | 5.147207e-4 |
GO:0006196 | AMP catabolic process | 5.218558e-4 |
GO:0035582 | negative regulation of BMP signaling pathway by extracellular sequestering of BMP | 5.232512e-4 |
GO:0046496 | nicotinamide nucleotide metabolic process | 5.269499e-4 |
GO:0001952 | regulation of cell-matrix adhesion | 5.347598e-4 |
GO:0030225 | macrophage differentiation | 5.360340e-4 |
GO:0050777 | negative regulation of immune response | 5.413306e-4 |
GO:0071731 | response to nitric oxide | 5.672650e-4 |
GO:0032236 | positive regulation of calcium ion transport via store-operated calcium channel activity | 5.672650e-4 |
GO:0000018 | regulation of DNA recombination | 5.674321e-4 |
GO:0045017 | glycerolipid biosynthetic process | 5.740333e-4 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 6.141661e-4 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 6.211688e-4 |
GO:0016142 | O-glycoside catabolic process | 6.211688e-4 |
GO:0001666 | response to hypoxia | 6.222363e-4 |
GO:2000147 | positive regulation of cell motility | 6.236298e-4 |
GO:0031572 | G2/M transition DNA damage checkpoint | 6.267795e-4 |
GO:0051146 | striated muscle cell differentiation | 6.294471e-4 |
GO:0019674 | NAD metabolic process | 6.303811e-4 |
GO:0055067 | monovalent inorganic cation homeostasis | 6.349675e-4 |
GO:0051716 | cellular response to stimulus | 6.367727e-4 |
GO:0007049 | cell cycle | 6.413124e-4 |
GO:0000279 | M phase | 6.416560e-4 |
GO:0015804 | neutral amino acid transport | 6.470023e-4 |
GO:0009629 | response to gravity | 6.492514e-4 |
GO:0007017 | microtubule-based process | 6.543005e-4 |
GO:0050864 | regulation of B cell activation | 6.614332e-4 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 6.797962e-4 |
GO:0003161 | cardiac conduction system development | 6.815083e-4 |
GO:0031398 | positive regulation of protein ubiquitination | 6.821228e-4 |
GO:0065009 | regulation of molecular function | 6.826532e-4 |
GO:0034976 | response to endoplasmic reticulum stress | 7.102080e-4 |
GO:0019725 | cellular homeostasis | 7.199370e-4 |
GO:0043497 | regulation of protein heterodimerization activity | 7.289233e-4 |
GO:0016601 | Rac protein signal transduction | 7.318895e-4 |
GO:0007202 | activation of phospholipase C activity | 7.350104e-4 |
GO:0033059 | cellular pigmentation | 7.351736e-4 |
GO:0019637 | organophosphate metabolic process | 7.523726e-4 |
GO:0070989 | oxidative demethylation | 7.578870e-4 |
GO:2000021 | regulation of ion homeostasis | 7.612186e-4 |
GO:0017038 | protein import | 7.623467e-4 |
GO:0051384 | response to glucocorticoid stimulus | 7.628212e-4 |
GO:0010288 | response to lead ion | 7.673799e-4 |
GO:0050810 | regulation of steroid biosynthetic process | 7.718984e-4 |
GO:0051345 | positive regulation of hydrolase activity | 7.765006e-4 |
GO:0033864 | positive regulation of NAD(P)H oxidase activity | 7.852033e-4 |
GO:0046477 | glycosylceramide catabolic process | 7.879748e-4 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 7.890861e-4 |
GO:0006413 | translational initiation | 8.006736e-4 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 8.229545e-4 |
GO:0009435 | NAD biosynthetic process | 8.278857e-4 |
GO:0019229 | regulation of vasoconstriction | 8.338043e-4 |
GO:0019438 | aromatic compound biosynthetic process | 8.352514e-4 |
GO:0035928 | rRNA import into mitochondrion | 8.407750e-4 |
GO:0051856 | adhesion to symbiont | 8.450901e-4 |
GO:0032026 | response to magnesium ion | 8.560700e-4 |
GO:0046688 | response to copper ion | 8.644206e-4 |
GO:0055094 | response to lipoprotein stimulus | 8.681588e-4 |
GO:0060427 | lung connective tissue development | 8.701370e-4 |
GO:0030011 | maintenance of cell polarity | 8.781189e-4 |
GO:2000683 | regulation of cellular response to X-ray | 8.836938e-4 |
GO:0051984 | positive regulation of chromosome segregation | 9.028588e-4 |
GO:0002457 | T cell antigen processing and presentation | 9.028588e-4 |
GO:0010477 | response to sulfur dioxide | 9.028588e-4 |
GO:0051276 | chromosome organization | 9.067664e-4 |
GO:0014070 | response to organic cyclic compound | 9.105797e-4 |
GO:0051851 | modification by host of symbiont morphology or physiology | 9.172997e-4 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 9.309617e-4 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 9.506294e-4 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 9.690229e-4 |
GO:0033261 | regulation of S phase | 9.913655e-4 |
GO:0090343 | positive regulation of cell aging | 9.979109e-4 |
GO:0048477 | oogenesis | 9.992570e-4 |
GO:0045069 | regulation of viral genome replication | 1.004685e-3 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 1.008824e-3 |
GO:0042427 | serotonin biosynthetic process | 1.010516e-3 |
GO:0044093 | positive regulation of molecular function | 1.016379e-3 |
GO:0031329 | regulation of cellular catabolic process | 1.026497e-3 |
GO:0033126 | positive regulation of GTP catabolic process | 1.028923e-3 |
GO:0010035 | response to inorganic substance | 1.049851e-3 |
GO:0019363 | pyridine nucleotide biosynthetic process | 1.056068e-3 |
GO:0006707 | cholesterol catabolic process | 1.062820e-3 |
GO:0018130 | heterocycle biosynthetic process | 1.076889e-3 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 1.105372e-3 |
GO:0035987 | endodermal cell differentiation | 1.108455e-3 |
GO:0050878 | regulation of body fluid levels | 1.111660e-3 |
GO:0019362 | pyridine nucleotide metabolic process | 1.130329e-3 |
GO:0071888 | macrophage apoptosis | 1.136772e-3 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 1.145952e-3 |
GO:0033591 | response to L-ascorbic acid | 1.172937e-3 |
GO:0030301 | cholesterol transport | 1.173740e-3 |
GO:0032237 | activation of store-operated calcium channel activity | 1.175037e-3 |
GO:0000075 | cell cycle checkpoint | 1.175665e-3 |
GO:0031023 | microtubule organizing center organization | 1.193815e-3 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 1.196458e-3 |
GO:0033004 | negative regulation of mast cell activation | 1.203399e-3 |
GO:0042759 | long-chain fatty acid biosynthetic process | 1.215811e-3 |
GO:0060193 | positive regulation of lipase activity | 1.220234e-3 |
GO:0051258 | protein polymerization | 1.241492e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 1.245994e-3 |
GO:0055093 | response to hyperoxia | 1.247909e-3 |
GO:0015031 | protein transport | 1.250074e-3 |
GO:0010518 | positive regulation of phospholipase activity | 1.252812e-3 |
GO:0051169 | nuclear transport | 1.264459e-3 |
GO:0046474 | glycerophospholipid biosynthetic process | 1.277870e-3 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 1.295471e-3 |
GO:0035024 | negative regulation of Rho protein signal transduction | 1.307294e-3 |
GO:0023019 | signal transduction involved in regulation of gene expression | 1.314517e-3 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 1.314836e-3 |
GO:0034613 | cellular protein localization | 1.331756e-3 |
GO:0061097 | regulation of protein tyrosine kinase activity | 1.339304e-3 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 1.342151e-3 |
GO:0032959 | inositol trisphosphate biosynthetic process | 1.348494e-3 |
GO:0019605 | butyrate metabolic process | 1.348494e-3 |
GO:0071674 | mononuclear cell migration | 1.354826e-3 |
GO:0002018 | renin-angiotensin regulation of aldosterone production | 1.354826e-3 |
GO:0045900 | negative regulation of translational elongation | 1.354826e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 1.367660e-3 |
GO:0006873 | cellular ion homeostasis | 1.378079e-3 |
GO:0016125 | sterol metabolic process | 1.390552e-3 |
GO:0045907 | positive regulation of vasoconstriction | 1.393406e-3 |
GO:0071732 | cellular response to nitric oxide | 1.399442e-3 |
GO:0008089 | anterograde axon cargo transport | 1.399442e-3 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 1.423922e-3 |
GO:0032232 | negative regulation of actin filament bundle assembly | 1.433925e-3 |
GO:0007156 | homophilic cell adhesion | 1.441942e-3 |
GO:0048739 | cardiac muscle fiber development | 1.446747e-3 |
GO:0032700 | negative regulation of interleukin-17 production | 1.457546e-3 |
GO:0048669 | collateral sprouting in absence of injury | 1.460181e-3 |
GO:0015801 | aromatic amino acid transport | 1.478432e-3 |
GO:0006913 | nucleocytoplasmic transport | 1.483575e-3 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.486199e-3 |
GO:0043547 | positive regulation of GTPase activity | 1.488866e-3 |
GO:0046473 | phosphatidic acid metabolic process | 1.495237e-3 |
GO:0048671 | negative regulation of collateral sprouting | 1.512369e-3 |
GO:0042559 | pteridine-containing compound biosynthetic process | 1.537769e-3 |
GO:0060298 | positive regulation of sarcomere organization | 1.542827e-3 |
GO:0022600 | digestive system process | 1.543416e-3 |
GO:0007623 | circadian rhythm | 1.561948e-3 |
GO:0016485 | protein processing | 1.567979e-3 |
GO:0071158 | positive regulation of cell cycle arrest | 1.597086e-3 |
GO:0021549 | cerebellum development | 1.604232e-3 |
GO:0035583 | negative regulation of transforming growth factor beta receptor signaling pathway by extracellular sequestering of TGFbeta | 1.607302e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 1.612602e-3 |
GO:0033693 | neurofilament bundle assembly | 1.640867e-3 |
GO:0032438 | melanosome organization | 1.644442e-3 |
GO:0046886 | positive regulation of hormone biosynthetic process | 1.651304e-3 |
GO:0006911 | phagocytosis, engulfment | 1.653779e-3 |
GO:0048583 | regulation of response to stimulus | 1.660750e-3 |
GO:0055078 | sodium ion homeostasis | 1.666674e-3 |
GO:0060191 | regulation of lipase activity | 1.690681e-3 |
GO:0008610 | lipid biosynthetic process | 1.695182e-3 |
GO:0070727 | cellular macromolecule localization | 1.713092e-3 |
GO:0021589 | cerebellum structural organization | 1.714534e-3 |
GO:0060904 | regulation of protein folding in endoplasmic reticulum | 1.714534e-3 |
GO:0001787 | natural killer cell proliferation | 1.714534e-3 |
GO:0051365 | cellular response to potassium ion starvation | 1.726516e-3 |
GO:0055002 | striated muscle cell development | 1.780381e-3 |
GO:0045124 | regulation of bone resorption | 1.787421e-3 |
GO:0070884 | regulation of calcineurin-NFAT signaling pathway | 1.808963e-3 |
GO:0001556 | oocyte maturation | 1.820873e-3 |
GO:0051604 | protein maturation | 1.836445e-3 |
GO:0046470 | phosphatidylcholine metabolic process | 1.839271e-3 |
GO:0006325 | chromatin organization | 1.854699e-3 |
GO:0023035 | CD40 signaling pathway | 1.865538e-3 |
GO:0046629 | gamma-delta T cell activation | 1.865538e-3 |
GO:0019068 | virion assembly | 1.865538e-3 |
GO:0006457 | protein folding | 1.882230e-3 |
GO:0031062 | positive regulation of histone methylation | 1.883386e-3 |
GO:0032069 | regulation of nuclease activity | 1.897009e-3 |
GO:0042439 | ethanolamine-containing compound metabolic process | 1.899865e-3 |
GO:0015918 | sterol transport | 1.938875e-3 |
GO:0015851 | nucleobase transport | 1.947300e-3 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 1.948910e-3 |
GO:0006725 | cellular aromatic compound metabolic process | 1.970654e-3 |
GO:0021575 | hindbrain morphogenesis | 1.971394e-3 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 1.975121e-3 |
GO:0032350 | regulation of hormone metabolic process | 2.015043e-3 |
GO:0009125 | nucleoside monophosphate catabolic process | 2.042661e-3 |
GO:0042742 | defense response to bacterium | 2.114619e-3 |
GO:0051282 | regulation of sequestering of calcium ion | 2.115844e-3 |
GO:0051297 | centrosome organization | 2.141929e-3 |
GO:0032320 | positive regulation of Ras GTPase activity | 2.150749e-3 |
GO:0051492 | regulation of stress fiber assembly | 2.162899e-3 |
GO:0050849 | negative regulation of calcium-mediated signaling | 2.195395e-3 |
GO:0042542 | response to hydrogen peroxide | 2.196284e-3 |
GO:0006639 | acylglycerol metabolic process | 2.251260e-3 |
GO:0002683 | negative regulation of immune system process | 2.257639e-3 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 2.265809e-3 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 2.265809e-3 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 2.265809e-3 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 2.265809e-3 |
GO:0046949 | fatty-acyl-CoA biosynthetic process | 2.266352e-3 |
GO:0051354 | negative regulation of oxidoreductase activity | 2.297723e-3 |
GO:0033121 | regulation of purine nucleotide catabolic process | 2.305676e-3 |
GO:0040017 | positive regulation of locomotion | 2.314809e-3 |
GO:0016569 | covalent chromatin modification | 2.364210e-3 |
GO:0006699 | bile acid biosynthetic process | 2.391262e-3 |
GO:0006930 | substrate-dependent cell migration, cell extension | 2.392226e-3 |
GO:0021860 | pyramidal neuron development | 2.396568e-3 |
GO:0016137 | glycoside metabolic process | 2.396568e-3 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 2.415712e-3 |
GO:0006641 | triglyceride metabolic process | 2.427325e-3 |
GO:0071453 | cellular response to oxygen levels | 2.444897e-3 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 2.487317e-3 |
GO:0043950 | positive regulation of cAMP-mediated signaling | 2.548247e-3 |
GO:0018095 | protein polyglutamylation | 2.548247e-3 |
GO:0043117 | positive regulation of vascular permeability | 2.553619e-3 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 2.581448e-3 |
GO:0002577 | regulation of antigen processing and presentation | 2.589843e-3 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 2.600612e-3 |
GO:0048096 | chromatin-mediated maintenance of transcription | 2.600612e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0018924 | mandelate metabolic process | 1.358381e-12 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 1.862096e-9 |
GO:0003012 | muscle system process | 7.784918e-8 |
GO:0018094 | protein polyglycylation | 1.134680e-7 |
GO:0002252 | immune effector process | 1.157029e-7 |
GO:0006955 | immune response | 1.440164e-7 |
GO:0000059 | protein import into nucleus, docking | 2.070374e-7 |
GO:0042938 | dipeptide transport | 2.759982e-7 |
GO:0001682 | tRNA 5'-leader removal | 4.230784e-7 |
GO:0016078 | tRNA catabolic process | 4.230784e-7 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 9.516867e-7 |
GO:0090310 | negative regulation of methylation-dependent chromatin silencing | 1.120668e-6 |
GO:0009236 | cobalamin biosynthetic process | 1.434746e-6 |
GO:0005980 | glycogen catabolic process | 1.586307e-6 |
GO:0043032 | positive regulation of macrophage activation | 2.241779e-6 |
GO:0002443 | leukocyte mediated immunity | 4.587349e-6 |
GO:0034661 | ncRNA catabolic process | 4.595416e-6 |
GO:0006936 | muscle contraction | 5.971611e-6 |
GO:0045815 | positive regulation of gene expression, epigenetic | 7.810170e-6 |
GO:0006707 | cholesterol catabolic process | 7.810170e-6 |
GO:0051384 | response to glucocorticoid stimulus | 7.848885e-6 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 8.594224e-6 |
GO:0070365 | hepatocyte differentiation | 9.388051e-6 |
GO:0007494 | midgut development | 1.038576e-5 |
GO:0006857 | oligopeptide transport | 1.238117e-5 |
GO:0031960 | response to corticosteroid stimulus | 1.676085e-5 |
GO:0042891 | antibiotic transport | 2.001282e-5 |
GO:0009235 | cobalamin metabolic process | 2.001282e-5 |
GO:0032092 | positive regulation of protein binding | 2.382504e-5 |
GO:0001812 | positive regulation of type I hypersensitivity | 2.689651e-5 |
GO:0043030 | regulation of macrophage activation | 2.717027e-5 |
GO:0002561 | basophil degranulation | 2.751402e-5 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 2.751402e-5 |
GO:0051099 | positive regulation of binding | 2.838514e-5 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 3.419585e-5 |
GO:0010842 | retina layer formation | 3.430735e-5 |
GO:0006959 | humoral immune response | 3.726168e-5 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 5.056806e-5 |
GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity | 5.549939e-5 |
GO:0006956 | complement activation | 5.990589e-5 |
GO:0006603 | phosphocreatine metabolic process | 6.003443e-5 |
GO:0044238 | primary metabolic process | 6.007437e-5 |
GO:0045575 | basophil activation | 6.228639e-5 |
GO:0032057 | negative regulation of translational initiation in response to stress | 7.279859e-5 |
GO:0021985 | neurohypophysis development | 7.279859e-5 |
GO:0031936 | negative regulation of chromatin silencing | 7.476022e-5 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 7.771628e-5 |
GO:0007109 | cytokinesis, completion of separation | 8.243188e-5 |
GO:0019098 | reproductive behavior | 8.651296e-5 |
GO:0006730 | one-carbon metabolic process | 9.057545e-5 |
GO:0043170 | macromolecule metabolic process | 9.062009e-5 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 9.614827e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 9.681592e-5 |
GO:0072376 | protein activation cascade | 1.084666e-4 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 1.097453e-4 |
GO:0034113 | heterotypic cell-cell adhesion | 1.143056e-4 |
GO:0060968 | regulation of gene silencing | 1.143056e-4 |
GO:0019538 | protein metabolic process | 1.206983e-4 |
GO:0019882 | antigen processing and presentation | 1.207967e-4 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 1.208308e-4 |
GO:0060969 | negative regulation of gene silencing | 1.210407e-4 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.214147e-4 |
GO:0006304 | DNA modification | 1.303834e-4 |
GO:0000272 | polysaccharide catabolic process | 1.379420e-4 |
GO:0031935 | regulation of chromatin silencing | 1.409853e-4 |
GO:0002250 | adaptive immune response | 1.465600e-4 |
GO:0001810 | regulation of type I hypersensitivity | 1.496929e-4 |
GO:0001805 | positive regulation of type III hypersensitivity | 1.496929e-4 |
GO:0006957 | complement activation, alternative pathway | 1.571339e-4 |
GO:0048048 | embryonic eye morphogenesis | 1.585664e-4 |
GO:0046314 | phosphocreatine biosynthetic process | 1.595394e-4 |
GO:0021979 | hypothalamus cell differentiation | 1.595394e-4 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 1.595394e-4 |
GO:0046599 | regulation of centriole replication | 1.701173e-4 |
GO:0006909 | phagocytosis | 1.713591e-4 |
GO:0090037 | positive regulation of protein kinase C signaling cascade | 1.891550e-4 |
GO:0046784 | intronless viral mRNA export from host nucleus | 1.909988e-4 |
GO:0033692 | cellular polysaccharide biosynthetic process | 1.921635e-4 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 1.974882e-4 |
GO:0002449 | lymphocyte mediated immunity | 2.322240e-4 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 2.365970e-4 |
GO:0002444 | myeloid leukocyte mediated immunity | 2.394860e-4 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.705435e-4 |
GO:0051607 | defense response to virus | 2.827807e-4 |
GO:0006949 | syncytium formation | 2.867754e-4 |
GO:0033120 | positive regulation of RNA splicing | 2.954599e-4 |
GO:0071360 | cellular response to exogenous dsRNA | 3.027167e-4 |
GO:0048596 | embryonic camera-type eye morphogenesis | 3.079481e-4 |
GO:0001788 | antibody-dependent cellular cytotoxicity | 3.088053e-4 |
GO:0007618 | mating | 3.114202e-4 |
GO:0045321 | leukocyte activation | 3.128707e-4 |
GO:0006399 | tRNA metabolic process | 3.209241e-4 |
GO:0050855 | regulation of B cell receptor signaling pathway | 3.210909e-4 |
GO:0046500 | S-adenosylmethionine metabolic process | 3.280233e-4 |
GO:0034637 | cellular carbohydrate biosynthetic process | 3.502703e-4 |
GO:0060206 | estrous cycle phase | 3.535767e-4 |
GO:0006694 | steroid biosynthetic process | 3.551646e-4 |
GO:0043248 | proteasome assembly | 3.719607e-4 |
GO:0001775 | cell activation | 3.817039e-4 |
GO:0035510 | DNA dealkylation | 4.022546e-4 |
GO:0000165 | MAPKKK cascade | 4.065780e-4 |
GO:0030157 | pancreatic juice secretion | 4.219838e-4 |
GO:0032259 | methylation | 4.235486e-4 |
GO:0000920 | cytokinetic cell separation | 4.337031e-4 |
GO:0051209 | release of sequestered calcium ion into cytosol | 4.362497e-4 |
GO:0032689 | negative regulation of interferon-gamma production | 4.369240e-4 |
GO:0042304 | regulation of fatty acid biosynthetic process | 4.456514e-4 |
GO:0070375 | BMK cascade | 4.613702e-4 |
GO:0002699 | positive regulation of immune effector process | 4.653054e-4 |
GO:0002697 | regulation of immune effector process | 4.802375e-4 |
GO:0000018 | regulation of DNA recombination | 4.895237e-4 |
GO:0032674 | regulation of interleukin-5 production | 4.914630e-4 |
GO:0048239 | negative regulation of DNA recombination at telomere | 4.929825e-4 |
GO:0006430 | lysyl-tRNA aminoacylation | 4.929825e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 4.995214e-4 |
GO:0060010 | Sertoli cell fate commitment | 5.032916e-4 |
GO:0045793 | positive regulation of cell size | 5.386705e-4 |
GO:0008299 | isoprenoid biosynthetic process | 5.388189e-4 |
GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport | 5.451498e-4 |
GO:0000768 | syncytium formation by plasma membrane fusion | 5.616703e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 5.731978e-4 |
GO:0045922 | negative regulation of fatty acid metabolic process | 6.094285e-4 |
GO:0048388 | endosomal lumen acidification | 6.146070e-4 |
GO:0030518 | steroid hormone receptor signaling pathway | 6.238622e-4 |
GO:0060402 | calcium ion transport into cytosol | 6.367722e-4 |
GO:0006937 | regulation of muscle contraction | 6.388177e-4 |
GO:0046129 | purine ribonucleoside biosynthetic process | 6.740693e-4 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 6.771785e-4 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 7.440915e-4 |
GO:0061072 | iris morphogenesis | 7.453786e-4 |
GO:0042628 | mating plug formation | 7.453786e-4 |
GO:0031034 | myosin filament assembly | 7.453786e-4 |
GO:0044275 | cellular carbohydrate catabolic process | 7.477966e-4 |
GO:0016126 | sterol biosynthetic process | 7.615671e-4 |
GO:0001938 | positive regulation of endothelial cell proliferation | 7.841915e-4 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 8.021355e-4 |
GO:0055069 | zinc ion homeostasis | 8.051893e-4 |
GO:0060297 | regulation of sarcomere organization | 8.673640e-4 |
GO:0006706 | steroid catabolic process | 8.903592e-4 |
GO:0019724 | B cell mediated immunity | 8.925036e-4 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 8.936719e-4 |
GO:0032816 | positive regulation of natural killer cell activation | 8.981932e-4 |
GO:0014889 | muscle atrophy | 9.332124e-4 |
GO:0051351 | positive regulation of ligase activity | 9.556239e-4 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 9.584509e-4 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 9.789718e-4 |
GO:0007621 | negative regulation of female receptivity | 1.001103e-3 |
GO:0007520 | myoblast fusion | 1.057567e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.151151e-3 |
GO:0060401 | cytosolic calcium ion transport | 1.159942e-3 |
GO:0034660 | ncRNA metabolic process | 1.179777e-3 |
GO:0051823 | regulation of synapse structural plasticity | 1.220409e-3 |
GO:0046631 | alpha-beta T cell activation | 1.225691e-3 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 1.256669e-3 |
GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | 1.261244e-3 |
GO:0015808 | L-alanine transport | 1.261244e-3 |
GO:0051282 | regulation of sequestering of calcium ion | 1.310047e-3 |
GO:0045062 | extrathymic T cell selection | 1.321148e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1.321148e-3 |
GO:0016064 | immunoglobulin mediated immune response | 1.324679e-3 |
GO:0050847 | progesterone receptor signaling pathway | 1.382414e-3 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 1.384737e-3 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 1.395879e-3 |
GO:0030318 | melanocyte differentiation | 1.396292e-3 |
GO:0001959 | regulation of cytokine-mediated signaling pathway | 1.406422e-3 |
GO:0006575 | cellular modified amino acid metabolic process | 1.432078e-3 |
GO:0048002 | antigen processing and presentation of peptide antigen | 1.455763e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.470237e-3 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 1.483489e-3 |
GO:0005978 | glycogen biosynthetic process | 1.502823e-3 |
GO:0032781 | positive regulation of ATPase activity | 1.513549e-3 |
GO:0009110 | vitamin biosynthetic process | 1.528581e-3 |
GO:0032656 | regulation of interleukin-13 production | 1.528581e-3 |
GO:0070509 | calcium ion import | 1.530350e-3 |
GO:0016074 | snoRNA metabolic process | 1.530350e-3 |
GO:0001842 | neural fold formation | 1.530350e-3 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 1.630574e-3 |
GO:0030890 | positive regulation of B cell proliferation | 1.679805e-3 |
GO:0060759 | regulation of response to cytokine stimulus | 1.702819e-3 |
GO:0001826 | inner cell mass cell differentiation | 1.715985e-3 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 1.718559e-3 |
GO:0060298 | positive regulation of sarcomere organization | 1.734323e-3 |
GO:0050931 | pigment cell differentiation | 1.792958e-3 |
GO:0046605 | regulation of centrosome cycle | 1.800480e-3 |
GO:0007320 | insemination | 1.818885e-3 |
GO:0032506 | cytokinetic process | 1.906855e-3 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 1.909801e-3 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 1.909801e-3 |
GO:0008152 | metabolic process | 1.939604e-3 |
GO:0030825 | positive regulation of cGMP metabolic process | 1.978787e-3 |
GO:0071625 | vocalization behavior | 1.978787e-3 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 2.016038e-3 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 2.016038e-3 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 2.016038e-3 |
GO:0060210 | metestrus | 2.016038e-3 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 2.016038e-3 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 2.016038e-3 |
GO:0006975 | DNA damage induced protein phosphorylation | 2.066871e-3 |
GO:0006401 | RNA catabolic process | 2.079996e-3 |
GO:0031341 | regulation of cell killing | 2.094944e-3 |
GO:2000821 | regulation of grooming behavior | 2.102979e-3 |
GO:0040032 | post-embryonic body morphogenesis | 2.118624e-3 |
GO:0031343 | positive regulation of cell killing | 2.207331e-3 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 2.231778e-3 |
GO:0006520 | cellular amino acid metabolic process | 2.293498e-3 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 2.330975e-3 |
GO:0032696 | negative regulation of interleukin-13 production | 2.332554e-3 |
GO:0031338 | regulation of vesicle fusion | 2.332554e-3 |
GO:0071173 | spindle assembly checkpoint | 2.348436e-3 |
GO:0016052 | carbohydrate catabolic process | 2.391702e-3 |
GO:0071391 | cellular response to estrogen stimulus | 2.411479e-3 |
GO:0015959 | diadenosine polyphosphate metabolic process | 2.471432e-3 |
GO:0034589 | hydroxyproline transport | 2.471432e-3 |
GO:0015826 | threonine transport | 2.471432e-3 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 2.471432e-3 |
GO:0002369 | T cell cytokine production | 2.473084e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 2.480909e-3 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 2.486224e-3 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 2.508490e-3 |
GO:0051412 | response to corticosterone stimulus | 2.511821e-3 |
GO:0007243 | intracellular protein kinase cascade | 2.532687e-3 |
GO:0006508 | proteolysis | 2.569136e-3 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 2.580882e-3 |
GO:0019511 | peptidyl-proline hydroxylation | 2.597323e-3 |
GO:0043500 | muscle adaptation | 2.618793e-3 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 2.618793e-3 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 2.692775e-3 |
GO:0035329 | hippo signaling cascade | 2.692775e-3 |
GO:0031347 | regulation of defense response | 2.718030e-3 |
GO:0031342 | negative regulation of cell killing | 2.743974e-3 |
GO:0002440 | production of molecular mediator of immune response | 2.809228e-3 |
GO:0015825 | L-serine transport | 2.951955e-3 |
GO:0006531 | aspartate metabolic process | 2.951955e-3 |
GO:0002710 | negative regulation of T cell mediated immunity | 3.036078e-3 |
GO:0032713 | negative regulation of interleukin-4 production | 3.041257e-3 |
GO:0060067 | cervix development | 3.070120e-3 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 3.105106e-3 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 3.105106e-3 |
GO:0031642 | negative regulation of myelination | 3.136856e-3 |
GO:0042364 | water-soluble vitamin biosynthetic process | 3.171952e-3 |
GO:0045947 | negative regulation of translational initiation | 3.171952e-3 |
GO:0001936 | regulation of endothelial cell proliferation | 3.204619e-3 |
GO:0035914 | skeletal muscle cell differentiation | 3.223460e-3 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 3.463970e-3 |
GO:0031340 | positive regulation of vesicle fusion | 3.469130e-3 |
GO:0021905 | forebrain-midbrain boundary formation | 3.484273e-3 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 3.484273e-3 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 3.484273e-3 |
GO:0006106 | fumarate metabolic process | 3.484273e-3 |
GO:0003322 | pancreatic A cell development | 3.484273e-3 |
GO:0001757 | somite specification | 3.484273e-3 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 3.499217e-3 |
GO:0015879 | carnitine transport | 3.499217e-3 |
GO:0016556 | mRNA modification | 3.499217e-3 |
GO:2000822 | regulation of behavioral fear response | 3.545607e-3 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 3.604314e-3 |
GO:0090281 | negative regulation of calcium ion import | 3.699053e-3 |
GO:0071584 | negative regulation of zinc ion import | 3.699053e-3 |
GO:0080009 | mRNA methylation | 3.699053e-3 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 3.767365e-3 |
GO:0030852 | regulation of granulocyte differentiation | 3.795424e-3 |
GO:0010824 | regulation of centrosome duplication | 3.847400e-3 |
GO:0001866 | NK T cell proliferation | 3.853538e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 3.877121e-3 |
GO:0051382 | kinetochore assembly | 3.914694e-3 |
GO:0055007 | cardiac muscle cell differentiation | 3.955496e-3 |
GO:0032328 | alanine transport | 3.971303e-3 |
GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis | 3.971303e-3 |
GO:0002741 | positive regulation of cytokine secretion involved in immune response | 3.971303e-3 |
GO:0000731 | DNA synthesis involved in DNA repair | 3.971303e-3 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 3.988140e-3 |
GO:0045621 | positive regulation of lymphocyte differentiation | 4.017459e-3 |
GO:0014044 | Schwann cell development | 4.074336e-3 |
GO:0050803 | regulation of synapse structure and activity | 4.140643e-3 |
GO:0045765 | regulation of angiogenesis | 4.157909e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 4.164345e-3 |
GO:0031577 | spindle checkpoint | 4.165678e-3 |
GO:0006396 | RNA processing | 4.198172e-3 |
GO:0002673 | regulation of acute inflammatory response | 4.249721e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.275440e-3 |
GO:0030865 | cortical cytoskeleton organization | 4.469102e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 4.487950e-3 |
GO:0022011 | myelination in peripheral nervous system | 4.519333e-3 |
GO:0032375 | negative regulation of cholesterol transport | 4.560935e-3 |
GO:0008033 | tRNA processing | 4.600700e-3 |
GO:0045214 | sarcomere organization | 4.689934e-3 |
GO:0002700 | regulation of production of molecular mediator of immune response | 4.699165e-3 |
GO:0045065 | cytotoxic T cell differentiation | 4.731324e-3 |
GO:0021506 | anterior neuropore closure | 4.731324e-3 |
GO:0030888 | regulation of B cell proliferation | 4.785335e-3 |
GO:0043950 | positive regulation of cAMP-mediated signaling | 4.813239e-3 |
GO:0061037 | negative regulation of cartilage development | 4.874562e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 4.874562e-3 |
GO:0090257 | regulation of muscle system process | 5.006799e-3 |
GO:0002344 | B cell affinity maturation | 5.054468e-3 |
GO:0032814 | regulation of natural killer cell activation | 5.087620e-3 |
GO:0048313 | Golgi inheritance | 5.138057e-3 |
GO:0002551 | mast cell chemotaxis | 5.138057e-3 |
GO:0003416 | endochondral bone growth | 5.171907e-3 |
GO:0050776 | regulation of immune response | 5.210554e-3 |
GO:0060350 | endochondral bone morphogenesis | 5.249772e-3 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 5.406429e-3 |
GO:0032055 | negative regulation of translation in response to stress | 5.491274e-3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 5.491274e-3 |
GO:0045087 | innate immune response | 5.547105e-3 |
GO:0031076 | embryonic camera-type eye development | 5.768375e-3 |
GO:0015811 | L-cystine transport | 5.840410e-3 |
GO:0046633 | alpha-beta T cell proliferation | 5.876975e-3 |
GO:0080111 | DNA demethylation | 5.876975e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 5.876975e-3 |
GO:0002456 | T cell mediated immunity | 5.996550e-3 |
GO:0007617 | mating behavior | 6.035847e-3 |
GO:0060760 | positive regulation of response to cytokine stimulus | 6.046393e-3 |
GO:0031018 | endocrine pancreas development | 6.047473e-3 |
GO:0060907 | positive regulation of macrophage cytokine production | 6.179846e-3 |
GO:0003008 | system process | 6.259853e-3 |
GO:0042396 | phosphagen biosynthetic process | 6.310888e-3 |
GO:0048850 | hypophysis morphogenesis | 6.339720e-3 |
GO:0002831 | regulation of response to biotic stimulus | 6.343397e-3 |
GO:0032819 | positive regulation of natural killer cell proliferation | 6.377998e-3 |
GO:0030239 | myofibril assembly | 6.484294e-3 |
GO:0002521 | leukocyte differentiation | 6.530799e-3 |
GO:0046514 | ceramide catabolic process | 6.560927e-3 |
GO:0051385 | response to mineralocorticoid stimulus | 6.592848e-3 |
GO:0014902 | myotube differentiation | 6.700635e-3 |
GO:0006091 | generation of precursor metabolites and energy | 6.728510e-3 |
GO:0043623 | cellular protein complex assembly | 6.748092e-3 |
GO:0015909 | long-chain fatty acid transport | 6.775153e-3 |
GO:0071585 | detoxification of cadmium ion | 6.869622e-3 |
GO:0003105 | negative regulation of glomerular filtration | 6.869622e-3 |
GO:0060215 | primitive hemopoiesis | 6.890474e-3 |
GO:0032714 | negative regulation of interleukin-5 production | 6.890474e-3 |
GO:0033239 | negative regulation of cellular amine metabolic process | 6.928069e-3 |
GO:0044264 | cellular polysaccharide metabolic process | 6.937494e-3 |
GO:0006952 | defense response | 6.950067e-3 |
GO:0030970 | retrograde protein transport, ER to cytosol | 7.003715e-3 |
GO:0060591 | chondroblast differentiation | 7.064398e-3 |
GO:0032329 | serine transport | 7.212610e-3 |
GO:0043414 | macromolecule methylation | 7.253259e-3 |
GO:0051146 | striated muscle cell differentiation | 7.282363e-3 |
GO:0003417 | growth plate cartilage development | 7.345314e-3 |
GO:0046649 | lymphocyte activation | 7.546631e-3 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 7.565008e-3 |
GO:0002274 | myeloid leukocyte activation | 7.719235e-3 |
GO:0032649 | regulation of interferon-gamma production | 7.972400e-3 |
GO:0008037 | cell recognition | 8.033132e-3 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 8.053712e-3 |
GO:0021796 | cerebral cortex regionalization | 8.200390e-3 |
GO:0009913 | epidermal cell differentiation | 8.216043e-3 |
GO:0014732 | skeletal muscle atrophy | 8.273920e-3 |
GO:0048066 | developmental pigmentation | 8.287827e-3 |
GO:0051383 | kinetochore organization | 8.310215e-3 |
GO:0046929 | negative regulation of neurotransmitter secretion | 8.310215e-3 |
GO:0030217 | T cell differentiation | 8.421222e-3 |
GO:0009988 | cell-cell recognition | 8.666024e-3 |
GO:0002238 | response to molecule of fungal origin | 8.711149e-3 |
GO:0002920 | regulation of humoral immune response | 8.792816e-3 |
GO:0030520 | estrogen receptor signaling pathway | 8.810778e-3 |
GO:0030224 | monocyte differentiation | 8.833728e-3 |
GO:0042921 | glucocorticoid receptor signaling pathway | 8.849726e-3 |
GO:0002706 | regulation of lymphocyte mediated immunity | 8.904914e-3 |
GO:0000722 | telomere maintenance via recombination | 8.906926e-3 |
GO:0008202 | steroid metabolic process | 8.909985e-3 |
GO:0008284 | positive regulation of cell proliferation | 8.990148e-3 |
GO:0072236 | metanephric loop of Henle development | 9.014606e-3 |
GO:0048706 | embryonic skeletal system development | 9.017109e-3 |
GO:0030853 | negative regulation of granulocyte differentiation | 9.259424e-3 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 9.409191e-3 |
GO:0010038 | response to metal ion | 9.454256e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 9.596326e-3 |
GO:0014823 | response to activity | 9.684605e-3 |
GO:0032673 | regulation of interleukin-4 production | 9.735321e-3 |
GO:0051964 | negative regulation of synapse assembly | 9.802693e-3 |
GO:0071407 | cellular response to organic cyclic compound | 9.982263e-3 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.007400e-2 |
GO:0001778 | plasma membrane repair | 1.009224e-2 |
GO:0051168 | nuclear export | 1.024591e-2 |
GO:0045104 | intermediate filament cytoskeleton organization | 1.035189e-2 |
GO:0016051 | carbohydrate biosynthetic process | 1.039931e-2 |
GO:0032970 | regulation of actin filament-based process | 1.042401e-2 |
GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification | 1.044936e-2 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 1.056768e-2 |
GO:0007620 | copulation | 1.057936e-2 |
GO:0048562 | embryonic organ morphogenesis | 1.060025e-2 |
GO:0060696 | regulation of phospholipid catabolic process | 1.063984e-2 |
GO:0034260 | negative regulation of GTPase activity | 1.063984e-2 |
GO:0030162 | regulation of proteolysis | 1.100531e-2 |
GO:0042403 | thyroid hormone metabolic process | 1.110113e-2 |
GO:0042176 | regulation of protein catabolic process | 1.111176e-2 |
GO:0031032 | actomyosin structure organization | 1.113684e-2 |
GO:0001819 | positive regulation of cytokine production | 1.122652e-2 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 1.151649e-2 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 1.152337e-2 |
GO:0051961 | negative regulation of nervous system development | 1.152768e-2 |
GO:0045830 | positive regulation of isotype switching | 1.156683e-2 |
GO:2000484 | positive regulation of interleukin-8 secretion | 1.160666e-2 |
GO:0003344 | pericardium morphogenesis | 1.160666e-2 |
GO:0034384 | high-density lipoprotein particle clearance | 1.162934e-2 |
GO:0050871 | positive regulation of B cell activation | 1.187204e-2 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.196286e-2 |
GO:0007052 | mitotic spindle organization | 1.196286e-2 |
GO:0035051 | cardiac cell differentiation | 1.216320e-2 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 1.229779e-2 |
GO:0045833 | negative regulation of lipid metabolic process | 1.245176e-2 |
GO:0045924 | regulation of female receptivity | 1.246785e-2 |
GO:0002367 | cytokine production involved in immune response | 1.246785e-2 |
GO:0071295 | cellular response to vitamin | 1.256077e-2 |
GO:0045576 | mast cell activation | 1.262446e-2 |
GO:0048096 | chromatin-mediated maintenance of transcription | 1.271555e-2 |
GO:0009584 | detection of visible light | 1.272213e-2 |
GO:0034605 | cellular response to heat | 1.275713e-2 |
GO:0046632 | alpha-beta T cell differentiation | 1.285192e-2 |
GO:0051216 | cartilage development | 1.290861e-2 |
GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness | 1.295189e-2 |
GO:0072054 | renal outer medulla development | 1.308700e-2 |
GO:0010922 | positive regulation of phosphatase activity | 1.310762e-2 |
GO:0003056 | regulation of vascular smooth muscle contraction | 1.315237e-2 |
GO:0061088 | regulation of sequestering of zinc ion | 1.315237e-2 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 1.315237e-2 |
GO:0006939 | smooth muscle contraction | 1.319392e-2 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 1.327035e-2 |
GO:0045103 | intermediate filament-based process | 1.342079e-2 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.346193e-2 |
GO:0030866 | cortical actin cytoskeleton organization | 1.357279e-2 |
GO:0009066 | aspartate family amino acid metabolic process | 1.358428e-2 |
GO:0071222 | cellular response to lipopolysaccharide | 1.380030e-2 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 1.393782e-2 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 1.393782e-2 |
GO:0006406 | mRNA export from nucleus | 1.412891e-2 |
GO:0043631 | RNA polyadenylation | 1.424444e-2 |
GO:0021797 | forebrain anterior/posterior pattern specification | 1.424858e-2 |
GO:0070198 | protein localization to chromosome, telomeric region | 1.456007e-2 |
GO:0030050 | vesicle transport along actin filament | 1.456007e-2 |
GO:0060192 | negative regulation of lipase activity | 1.484197e-2 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 1.484700e-2 |
GO:0090304 | nucleic acid metabolic process | 1.492511e-2 |
GO:0072061 | inner medullary collecting duct development | 1.509263e-2 |
GO:0072060 | outer medullary collecting duct development | 1.509263e-2 |
GO:0043049 | otic placode formation | 1.509263e-2 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.509263e-2 |
GO:0006474 | N-terminal protein amino acid acetylation | 1.515199e-2 |
GO:0000187 | activation of MAPK activity | 1.517320e-2 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.534896e-2 |
GO:0031123 | RNA 3'-end processing | 1.538490e-2 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.560302e-2 |
GO:0003306 | Wnt receptor signaling pathway involved in heart development | 1.561812e-2 |
GO:0042063 | gliogenesis | 1.575892e-2 |
GO:0042098 | T cell proliferation | 1.576387e-2 |
GO:0001525 | angiogenesis | 1.595406e-2 |
GO:0045637 | regulation of myeloid cell differentiation | 1.603023e-2 |
GO:0030212 | hyaluronan metabolic process | 1.612049e-2 |
GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification | 1.614020e-2 |
GO:0009086 | methionine biosynthetic process | 1.621757e-2 |
GO:0007015 | actin filament organization | 1.622541e-2 |
GO:0030522 | intracellular receptor mediated signaling pathway | 1.629628e-2 |
GO:0006479 | protein methylation | 1.632803e-2 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 1.648381e-2 |
GO:0045599 | negative regulation of fat cell differentiation | 1.666363e-2 |
GO:0042100 | B cell proliferation | 1.672883e-2 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 1.685386e-2 |
GO:0097107 | postsynaptic density assembly | 1.694482e-2 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.694482e-2 |
GO:0015798 | myo-inositol transport | 1.694482e-2 |
GO:0050853 | B cell receptor signaling pathway | 1.698694e-2 |
GO:0042404 | thyroid hormone catabolic process | 1.706493e-2 |
GO:0006910 | phagocytosis, recognition | 1.716973e-2 |
GO:0043402 | glucocorticoid mediated signaling pathway | 1.720405e-2 |
GO:0044111 | development involved in symbiotic interaction | 1.720405e-2 |
GO:0019089 | transmission of virus | 1.720405e-2 |
GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | 1.720405e-2 |
GO:2000021 | regulation of ion homeostasis | 1.720882e-2 |
GO:0045191 | regulation of isotype switching | 1.726186e-2 |
GO:0002674 | negative regulation of acute inflammatory response | 1.727237e-2 |
GO:0006405 | RNA export from nucleus | 1.733716e-2 |
GO:0009119 | ribonucleoside metabolic process | 1.744956e-2 |
GO:0050766 | positive regulation of phagocytosis | 1.746742e-2 |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 1.751359e-2 |
GO:0071216 | cellular response to biotic stimulus | 1.753239e-2 |
GO:0000271 | polysaccharide biosynthetic process | 1.764032e-2 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 1.783032e-2 |
GO:0006695 | cholesterol biosynthetic process | 1.783303e-2 |
GO:0007442 | hindgut morphogenesis | 1.792006e-2 |
GO:0032754 | positive regulation of interleukin-5 production | 1.800849e-2 |
GO:0010694 | positive regulation of alkaline phosphatase activity | 1.804911e-2 |
GO:0016071 | mRNA metabolic process | 1.822337e-2 |
GO:0045839 | negative regulation of mitosis | 1.830132e-2 |
GO:0002821 | positive regulation of adaptive immune response | 1.833855e-2 |
GO:0006555 | methionine metabolic process | 1.837555e-2 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.867066e-2 |
GO:0002377 | immunoglobulin production | 1.876130e-2 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 1.886598e-2 |
GO:0071577 | zinc ion transmembrane transport | 1.886598e-2 |
GO:0071313 | cellular response to caffeine | 1.894860e-2 |
GO:0048227 | plasma membrane to endosome transport | 1.894860e-2 |
GO:0001879 | detection of yeast | 1.894860e-2 |
GO:0042667 | auditory receptor cell fate specification | 1.894860e-2 |
GO:0045609 | positive regulation of auditory receptor cell differentiation | 1.894860e-2 |
GO:0045580 | regulation of T cell differentiation | 1.897934e-2 |
GO:0009309 | amine biosynthetic process | 1.900268e-2 |
GO:0032731 | positive regulation of interleukin-1 beta production | 1.911526e-2 |